Home Page

About Us

Investors

Inventors

Portfolio

Contact Us

Privacy Policy

Our History


2002

MetaCyte established
Founding partners: Jewish Hospital HealthCare Services, Norton Healthcare, University of Louisville, University of Louisville Hospital, and Louisville Medical Center Development Corporation


2002

ApoImmune joins MetaCyte portfolio


2004

Steve Gailar named MetaCyte president and CEO


2004

AllTranz founded


2004

3DR founded


2004

PGXL founded


2005

RhinoCyte founded


2005

Pradama founded


2005

EndoProtech founded


2005

InnoRem founded


2005

EndoProtech receives $200K KSTC Business R&D Voucher


2006

ImmunoTheragnostics founded


2006

Intrepid Bioinformatics founded


2006

ULSD, Inc. founded


2006

Pradama completes $500K Series A financing led by KSCF


2006

MetaCyte receives $750K KEDFA investment from DCI


2006

RhinoCyte completes $930K Series A financing led by KSCF


2006

ApoImmune completes $1.2M financing round led by KSCF and DCI


2006

PGxl Laboratories receives $500K investment from Nanogen


2007

Pradama completes $1.1M Series A1 financing led by Triathlon and KSCF


2007

AllTranz completes $1.76M in Series A financing


2008

MetaCyte begins operation as a subsidiary of the UofL Foundation


2008

ImmunoTheragnostics acquired by biosciences services company


2008

EndoProtech awarded $1M NIH STTR Phase II grant


2008

RhinoCyte receives FDA orphan drug designation for spinal cord injury


2008

RhinoCyte completes successful PreIND meeting


2008

ApoImmune secures $2M convertible note bridge financing


2008

RhinoCyte receives FDA orphan drug designation for ALS


2008

RhinoCyte completes $730K bridge financing to continue to fund key milestones


2009

AllTranz completes successful PreIND meeting


2009

ApoImmune completes successful PreIND meeting


2009

AllTranz completes first close on Series A1 financing of $400K to continue to fund key milestones


2009

RhinoCyte completes first close on Series A1 financing of $1.6M new money to fund IND submission


2009

TrackFive founded


2009

Eyevation founded


2009

AnosiaVax founded


2009

EndoProtech awarded $270K SBIR/STTR Matching Fund Phase 2 funding


2010

TrackFive Diagnostics receives $100,000 investment from Kentucky Enterprise Fund (KSTC)








July 18, 2011
Louisville Will Host the 9th Annual MidAmerica Healthcare Venture Forum, November 8-9, 2011 (External Link)

October 15, 2010
Intrepid Featured on BioForm (PDF)

July 16, 2010
Intrepid Bioinformatics Receives Investment, Meets Milestones

May 6, 2010
MetaCyte Business Lab Receives Mention in Nature (PDF)

March 31, 2010
MetaCyte Recognized for Innovation

March 15, 2010
Teresa Leezer Honored a Second Time for Excellence in Business Management

February 23, 2010
Gailar Addresses Leaders as Part of Innovation Panel

January 2010
Triathlon Medical Ventures and the Kentucky Seed Capital Fund Lead Investment in Louisville Start-Up

November 2009
MetaCyte Advisor Bill Strench Featured in Business First (External Link)

November 2009
EndoProtech Awarded $270,000 from Kentucky Cabinet for Economic Development

August 25, 2009
Pierce Named Interim Head of UofL Research (External Link)

July 1, 2009
AllTranz Named Top Innovator by National Venture Group

May 8, 2009
ApoImmune Finalist for "Best Early-Stage Vaccine Biotech" at World Vaccine Congress ViE Awards

September 12, 2008
MetaCyte Team Shows Off New Offices

June 18, 2008
Teresa Leezer Honored by Cambridge Who's Who for Excellence in Business Management

Summer 2006
A UofL research team led by Fred Roisen, Ph.D., has developed a breakthrough adult stem-cell therapy that repairs spinal-cord damage in paralyzed rats (External Link)